Innovate, a privately-held clinical stage biotechnology company, is focused on developing novel medicines for autoimmune/inflammatory disease. Our pipeline includes drug candidates for Celiac Disease, an unmet need, an adult orphan indication as well as ulcerative colitis. The Company is led by a strong management team with extensive business and regulatory experience. Innovate has all global rights to the products which are backed by more than 150 patents worldwide.
Innovate is currently developing three clinical stage assets: